InsiderTrades.com logo
Is This The Most Overlooked Gold Investment Strategy of 2024?
From Edge On The Street   |   Ad
There is little debate on the potential of gold in the next year and decade. The real issue becomes - what's the best gold investment strategy today? Some investors are opting for a unique "royalty" alternative that outshines other options like holding gold bullion or investing in volatile mining stocks.
Read this stunning report on a little-known gold

SBTX Insider Trading

Insider Ownership Percentage: 26.95%
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): £20,578.56

SkinBioTherapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at SkinBioTherapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

SkinBioTherapeutics Share Price & Price History

Current Price: GBX 16.50
Price Change: ▲ Price Increase of +0.125 (0.76%)
As of 12/11/2023 06:11 AM ET

This chart shows the closing price history over time for SBTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
All the trading advice you’ve ever received boils down to this
From DTI Trader   |   Ad
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
Drop everything and learn about the Income Calendar now.

SkinBioTherapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/6/2023Manprit Singh RandhawaInsiderSell89,472GBX 23£20,578.56
See Full Table
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
From Autonomix   |   Ad
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for SkinBioTherapeutics (LON:SBTX)

11.86% of SkinBioTherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

SkinBioTherapeutics logo
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health. It develops SkinBiotix technology that can enhance the formation of multi-protein complexes and prevent passage toxins, molecules, and ions, as well as pathogens; and AxisBiotix that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has a collaboration agreement with Croda Plc; and the University of Manchester to develop bacterial lysates in the prevention of periodontal gun disease. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.
Read More on SkinBioTherapeutics

Today's Range

Now: GBX 16.50
Low: 16.28
High: 16.50

50 Day Range

MA: GBX 22.01
Low: 16.29
High: 29

52 Week Range

Now: GBX 16.50
Low: 11
High: 29.50

Volume

50,687 shs

Average Volume

417,762 shs

Market Capitalization

£31.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.8

Who are the company insiders with the largest holdings of SkinBioTherapeutics?

SkinBioTherapeutics' top insider investors include:
  1. Manprit Singh Randhawa (Insider)
Learn More about top insider investors at SkinBioTherapeutics.
Is This The Most Overlooked Gold Investment Strategy of 2024?
From Edge On The Street   |   Ad
There is little debate on the potential of gold in the next year and decade. The real issue becomes - what's the best gold investment strategy today? Some investors are opting for a unique "royalty" alternative that outshines other options like holding gold bullion or investing in volatile mining stocks.
Read this stunning report on a little-known gold